Gold standard: Infant formula that mimics mother’s milk promotes bone and digestive health – Junlebao

The lipid structure Oleic-Palmitic-Oleic (OPO) can replicate benefits of breastfeeding, according to an ongoing randomised controlled trial (RCT) by dairy group Junlebao.

“While we provide infant formula, we’re using mother’s milk as the benchmark,”​ said Celia Ning, director of Junlebao Dairy Group, referencing the fact that breast milk is considered the gold standard for infant nutrition.

Ning was speaking at our Growth Asia Summit 2024 that was held in Singapore from 16 to 18 July.

Triglyceride is a major component of human milk fat. One of the main differences between breast milk and traditional cow formula is the positioning of the fatty acids, especially palmitic acid, along the glycerol backbone of the triglyceride structure.

In breast milk, palmitic acid is usually attached to the middle position – also known as the SN2 position – in the glycerol backbone.

About 51-88% of the palmitic acid in breast milk are positioned at the SN2 position, and only 10-20% are located at the SN2 position in regular cow formula.

Adding OPO to infant formula could make a difference as it mimics the fat structure in human breast milk, where 60-75% of the palmitic acid are at the SN2 position. This unique structure allows babies to absorb more nutrients.

“Clinical evidence has shown that adding infant formula with high SN2 to the diet can promote calcium absorption and increase bone mineral content. Additionally, in a Bunge-Junlebao joint study, casein phosphopeptides (CPP) is shown to enhance the absorption of mineral calcium, iron, and zinc,”​ said Ning.